FDx Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,390
Closed -$201K 739
2023
Q2
$201K Sell
3,390
-338
-9% -$20.2K 0.01% 716
2023
Q1
$233K Hold
3,728
0.01% 657
2022
Q4
$233K Buy
+3,728
New +$214K 0.01% 657
2022
Q3
Sell
-3,569
Closed -$210K 796
2022
Q2
$210K Buy
+3,569
New +$197K 0.01% 763
2022
Q1
Sell
-3,488
Closed -$212K 887
2021
Q4
$212K Buy
+3,488
New +$207K 0.01% 818
2020
Q1
Sell
-6,759
Closed -$274K 592
2019
Q4
$274K Buy
6,759
+282
+4% +$10.5K 0.02% 512
2019
Q3
$225K Sell
6,477
-1,264
-16% -$41.6K 0.02% 568
2019
Q2
$245K Buy
+7,741
New +$230K 0.01% 702
2018
Q4
Sell
-6,211
Closed -$235K 738
2018
Q3
$235K Sell
6,211
-385
-6% -$14.6K 0.01% 782
2018
Q2
$253K Buy
6,596
+86
+1% +$2.9K 0.01% 785
2018
Q1
$220K Sell
6,510
-1,071
-14% -$41.1K 0.01% 1094
2017
Q4
$337K Buy
7,581
+1,098
+17% +$50K 0.01% 971
2017
Q3
$325K Buy
+6,483
New +$331K 0.01% 1011

Other funds holding PBH

FDx Advisors's PBH Position: Q3 2023 in Review

FDx Advisors sold out of Prestige Consumer Healthcare (PBH) in Q3 2023, closing a stake of 3,390 shares — an estimated $201K sold.

FDx Advisors first reported a position in PBH in Q3 2017 and held it in 13 quarters. The position peaked at $337K in Q4 2017. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2023.

  • FDx Advisors reported no remaining Prestige Consumer Healthcare position as of Q3 2023 after selling out during the quarter.
  • FDx Advisors sold 3,390 Prestige Consumer Healthcare shares in Q3 2023, an estimated $201K.
  • FDx Advisors first reported a position in Prestige Consumer Healthcare in Q3 2017 and held it in 13 quarters.
  • FDx Advisors's Prestige Consumer Healthcare position peaked at $337K in Q4 2017.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2023.

Based on FDx Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.